AI & ChatGPT searches , social queriess for RITUXIMAB
Search references for RITUXIMAB. Phrases containing RITUXIMAB
See searches and references containing RITUXIMAB!
Search references for RITUXIMAB. Phrases containing RITUXIMAB
See searches and references containing RITUXIMAB!RITUXIMAB
Biopharmaceutical drug
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of
Rituximab
Chronic blistering skin disease
such as rituximab, which are increasingly being used as first-line treatment. In the summer of 2018, the FDA granted full approval to rituximab for this
Pemphigus_vulgaris
Treatment for non-Hodgkin lymphoma
corticosteroids. Sometimes the chimeric anti-CD20 monoclonal antibody, rituximab, is added to this treatment regimen to form the R-CHOP regimen. R-miniCHOP
CHOP_(chemotherapy)
Medical condition
90% to less than 20%. Immunosuppressants, such as glucocorticoids, and rituximab may also be used. Platelet transfusions are generally not recommended
Thrombotic thrombocytopenic purpura
Thrombotic_thrombocytopenic_purpura
Medical condition
positive for the B cell marker CD20. The anti-CD20 monoclonal antibody Rituximab has been used in lymphocyte predominant Hodgkin lymphoma with encouraging
Nodular lymphocyte predominant Hodgkin lymphoma
Nodular_lymphocyte_predominant_Hodgkin_lymphoma
Cancer originating in lymph nodes
of t-FL (e.g., the addition to standard chemotherapy of agents such as rituximab) have improved overall survival times. These newer regimens may also delay
Follicular_lymphoma
Autoimmune disease resulting in skeletal muscle weakness
treatment. Other immune suppressing medications may also be used including rituximab,azathioprine and especially mycophenolate. Nipocalimab (Imaavy) was approved
Myasthenia_gravis
Intensive chemotherapy regimen
It is often combined with rituximab. In this case it is called R-EPOCH or EPOCH-R. The R-EPOCH regimen consists of: Rituximab: an anti-CD20 monoclonal
EPOCH_(chemotherapy)
Artificial stimulation of the immune system to treat cancer
destruction by the immune system. Examples of such antibodies include rituximab (targeting CD-20), trastuzumab (targeting HER-2), and cetuximab (targeting
Cancer_immunotherapy
Autoimmune disease of skin and connective tissue characterized by large blisters
use corticosteroids.[citation needed] The anti-CD20 monoclonal antibody rituximab is effective in treating some otherwise refractory cases of pemphigoid
Bullous_pemphigoid
Hematological malignancy
(more than 3 years if combined with rituximab), after which remission occurs. BRAF inhibitors with or without rituximab may be restarted if there is relapsed
Hairy_cell_leukemia
lenalidomide rituximab trastuzumab bevacizumab adalimumab ledipasvir etanercept rituximab infliximab adalimumab ledipasvir etanercept infliximab rituximab adalimumab
List of largest selling pharmaceutical products
List_of_largest_selling_pharmaceutical_products
Chemical compound
(1:1) to receive acalabrutinib plus bendamustine and rituximab or placebo plus bendamustine and rituximab. The US Food and Drug Administration (FDA) granted
Acalabrutinib
Type of blood cancer
DLBCL is chemotherapy combined with monoclonal antibody therapy, usually rituximab. Through these treatments, more than half of all patients with DLBCL can
Diffuse_large_B-cell_lymphoma
Autoimmune disease with chronic blood vessel inflammation
as rituximab or cyclophosphamide and high-dose corticosteroids to control the symptoms of the disease, and azathioprine, methotrexate, or rituximab to
Granulomatosis with polyangiitis
Granulomatosis_with_polyangiitis
Anti-CD20 monoclonal antibody
Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. It is administered by intravenous infusion. The fixed-dose combination
Ocrelizumab
lymphoma. When combined with Rituximab it is called R-GemOx, R-GEMOX or GemOx-R, GEMOX-R. The [R]-GemOx regimen consists of: Rituximab - anti-CD20 monoclonal
GemOx
Pharmaceutical drug
large B-cell lymphoma; or, when used in combination with lenalidomide and rituximab, for the treatment of follicular lymphoma. Tafasitamab is a humanized
Tafasitamab
Medication used in cancer treatment
Additionally, ibrutinib down-modulates the expression of CD20 (target of rituximab/ofatumumab) by targeting the CXCR4/SDF1 axis. Together, these data are
Ibrutinib
Medication
follicular lymphoma as a second line treatment to a regimen containing rituximab. Obinutuzumab was not tested in pregnant women. Obinutuzumab has two black
Obinutuzumab
Medical condition
disseminated disease at presentation or lack of response to local treatment. Rituximab, the anti-CD20 chimeric antibody, is a key component of therapy. Responses
MALT_lymphoma
Chemical compound
(MCL), with or without prior rituximab-containing chemoimmunotherapy treatment, is bendamustine with mitoxantrone and rituximab. In Germany in 2012 it has
Bendamustine
Medical condition
promise in this technique treating anti-MAG neuropathies.[citation needed] Rituximab is considered to be one of the most promising drugs in the treatment of
Anti-MAG peripheral neuropathy
Anti-MAG_peripheral_neuropathy
Type of blood cancer
bendamustine with rituximab. Second line treatment may include fludarabine, combined with cyclophosphamide and/or mitoxantrone, usually with rituximab. Cladribine
Mantle_cell_lymphoma
Bone marrow cancer in which lymphocytes are overproduced
with cyclophosphamide) FR (fludarabine with rituximab) FCR (fludarabine, cyclophosphamide, and rituximab) Although the purine analogue fludarabine was
Chronic_lymphocytic_leukemia
Variant of a biopharmaceutical
follitropin alfa, infliximab, insulin aspart, insulin glargine, pegfilgrastim, rituximab, teriparatide, and trastuzumab. A research article about "Maximizing the
Biosimilar
Medical intervention
anti-CD20 monoclonal antibody rituximab (Rituxan, Mabthera) it is called R-DHAP or DHAP-R. [R]-DHAP regimen consists of: Rituximab, a monoclonal antibody, directed
DHAP_(chemotherapy)
Regimen commonly used in chemotherapy
Mayerhoefer ME, Lukas J, Zielinski CC, Müllauer L, Raderer M (2014). "Rituximab plus bendamustine is active in pretreated patients with extragastric marginal
Chemotherapy_regimen
Pharmaceutical drug
and a rituximab product for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma. Polivy in combination with rituximab, cyclophosphamide
Polatuzumab_vedotin
Type of blood and immune-system cancer
often treated differently from classic Hodgkin lymphoma, including using rituximab in combination with AVBD chemotherapy, though individual cases vary and
Hodgkin_lymphoma
Antibodies from clones of the same blood cell
ozogamicin Ipilimumab Nivolumab Ofatumumab Panitumumab Pembrolizumab Rituximab Trastuzumab Monoclonal antibodies used for autoimmune diseases include
Monoclonal_antibody
Type of autoimmune arthritis
folic acid. Rituximab combined with methotrexate appears to be more effective in improving symptoms compared to methotrexate alone. Rituximab works by decreasing
Rheumatoid_arthritis
Medical drug glass
2022. The phase III trial CHRONOS-3 compares copanlisib + rituximab with placebo + rituximab in patients with relapsed iNHL. Study completion is expected
Phosphoinositide 3-kinase inhibitor
Phosphoinositide_3-kinase_inhibitor
Chronic medical condition
sustained after discontinuation. Rintatolimod has been approved in Argentina. Rituximab, a drug that depletes B cells, was studied and found to be ineffective
Myalgic encephalomyelitis/chronic fatigue syndrome
Myalgic_encephalomyelitis/chronic_fatigue_syndrome
today[when?] with rituximab. This regimen is then called ICE-R or R-ICE or RICE. [R]-ICE regimen consists of:[citation needed] Rituximab - an anti-CD20 monoclonal
ICE_(chemotherapy)
Neurological disorder
Other common treatments include baclofen, intravenous immunoglobin, and rituximab. Limited but encouraging therapeutic experience of haematopoietic stem
Stiff-person_syndrome
Chemical compound
glucocorticoids. In the European Union, avacopan, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adults
Avacopan
Rare disease which results in brain inflammation
antibodies in the cerebrospinal fluid. Furthermore, cyclophosphamide and rituximab, drugs used to eliminate dysfunctional immune cells, are successful second-line
Anti-NMDA receptor encephalitis
Anti-NMDA_receptor_encephalitis
Cancer of the lymphatic system
regimen; these can be associated with rituximab. In older patients, treatment may be dose-adjusted EPOCH with rituximab. The effects of the chemotherapy,
Burkitt_lymphoma
Indian dermatologist
work in Vitiligo. He was also the first in India to report efficacy of Rituximab for treatment of Pemphigus He was selected as a fellow of National Academy
AJ_Kanwar
Chemotherapy regimen
R-HDAC, or R-HD-AraC (rituximab plus high-dose cytosine arabinoside) is a chemotherapy regimen that is used, alternating with R-Maxi-CHOP, as part of
R-HDAC
Medical condition
azathioprine, methotrexate, etanercept, cyclophosphamide, adalimumab, rituximab, and infliximab. Newer medications target interleukin-1 (IL-1), particularly
Adult-onset_Still's_disease
Medical condition with rash and bleeding risk
T cells can be influenced by medications that target B cells, such as rituximab. The diagnosis of ITP is a process of exclusion. First, it has to be determined
Immune thrombocytopenic purpura
Immune_thrombocytopenic_purpura
Group of lymphomas
immunotherapy (i.e. rituximab, or a combination (e.g. chlorambucil + rituximab or fludarabine + rituximab or bendamustine + rituximab) immunotherapy plus
Marginal_zone_lymphoma
Chemotherapy acronym
combination with monoclonal antibody Rituximab it is called R-ESHAP or ESHAP-R. R-ESHAP consists of: Rituximab, an anti-CD20-directed monoclonal antibody
ESHAP
Autoimmune disease in which the immune system attacks healthy tissue
azathioprine and mycophenolic acid as with newer biological therapies (rituximab and belimumab). In more severe cases, medications that modulate the immune
Lupus
South Korean biopharmaceutical company
CT-P10) is the first biosimilar of the reference monoclonal antibody rituximab that targets CD20 molecule primarily found on the surface of B-cells.
Celltrion
Species of bacteria
with watchful waiting or, if symptomatic, with the immunotherapy drug rituximab (given for 4 weeks) combined with the chemotherapy drug chlorambucil for
Helicobacter_pylori
Medical speciality of inflammatory diseases
methotrexate for moderate to severe rheumatoid arthritis. The biologic agent rituximab (anti-B cell therapy) is now licensed for use in refractory rheumatoid
Rheumatology
American multinational biopharmaceutical company
December 18, 2020. "FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)" (Press release). PR Newswire. December 17, 2020
Amgen
Type of blood cancer
treatment with ibrutinib and rituximab showed significantly higher disease progression-free survival than with rituximab alone. Autologous bone marrow
Waldenström_macroglobulinemia
Drugs that modify immune system response
with RITUXAN (rituximab)" (PDF). Roche Canada. 10 November 2006. Archived from the original (PDF) on 27 March 2014. "Rituxan- rituximab injection, solution"
Biological_response_modifier
Medication
multicenter, open-label trial of venetoclax with rituximab (VEN+R) versus bendamustine with rituximab (B+R) in 389 participants with CLL who had received
Venetoclax
Tumors that affect the blood, bone marrow, lymph, and lymphatic system
immunotherapy and—in some cases—a bone marrow transplant. The use of rituximab has been established for the treatment of B-cell–derived hematologic malignancies
Tumors of the hematopoietic and lymphoid tissues
Tumors_of_the_hematopoietic_and_lymphoid_tissues
List of drugs given to treat leukemia
Nelarabine Nilotinib Oblimersen Pegaspargase Pentostatin Ponatinib Prednisone Rituximab Tretinoin Vincristine "Drugs Approved for Leukemia - NCI". www.cancer
List_of_antileukemic_drugs
Blood disorder in which antibodies target red blood cells
common upon discontinuation of rituximab, but the medication can be restarted to achieve subsequent remission. Rituximab can be combined with bendamustine
Autoimmune_hemolytic_anemia
Medical treatment for lymphoma
monoclonal antibody rituximab. In this case the regimen is called R-MINE or MINE-R.[citation needed] The [R]-MINE regimen consists of: Rituximab - anti-CD20 monoclonal
MINE_(chemotherapy)
Kidney disease causing nephrotic syndrome
been used such as a calcineurin inhibitor, mycophenolate mofetil, and rituximab though studies on their effectiveness are fairly limited. There is no
Minimal_change_disease
Branch of medicine dealing with, or specializing in, cancer
treatments are widely used in oncology, with established therapies such as Rituximab for lymphoma and Trastuzumab for HER2-positive breast cancer, alongside
Oncology
Disease subtype
despite treatment with Rituximab, or have concurrent Kaposi sarcoma, additional chemotherapeutic agents are added to Rituximab. All patients with HIV
HHV-8-associated_MCD
Antibody that plays a crucial role in the immune function of mucous membranes
be difficult to treat even with usually effective medications such as rituximab. Vancomycin can induce a linear IgA bullous dermatosis in some patients
Immunoglobulin_A
Measure of the percentage of human antibodies in a transplant candidate's blood
In certain circumstances, plasma exchange, intravenous immunoglobulin, rituximab and other "antibody-directed" immune therapies may be employed, but this
Panel-reactive_antibody
Radioimmunotherapy treatment
to first-line chemotherapy. The treatment starts with an infusion of rituximab. This may be followed by an administration of indium-111 labeled ibritumomab
Ibritumomab_tiuxetan
Group of lymphoproliferative disorders
recommended for symptomatic patients. If symptoms are due to compression, then rituximab is recommended. If symptoms are due to an inflammatory syndrome, then
Castleman_disease
Chemotherapy regimen
In combination with Rituximab, this regimen is called R-FCM or R-FMC, or FCM-R, FMC-R. The [R]-FCM regimen contains Rituximab - anti-CD20 monoclonal
FCM_(chemotherapy)
Acute inflammation diseases of the optic nerve and spinal cord
ISSN 2056-676X. PMID 33093467. S2CID 224825516. Banerjee S, Butcher R. Rituximab for the Treatment of Neuromyelitis Optica Spectrum Disorder [Internet]
Neuromyelitis optica spectrum disorder
Neuromyelitis_optica_spectrum_disorder
Medication
Mosunetuzumab), CD20 (Glofitamab Ibritumomab Mosunetuzumab Obinutuzumab Ofatumumab Rituximab Tositumomab), CD30 (Brentuximab), CD52 (Alemtuzumab) myeloid: CD33 (Gemtuzumab
Elranatamab
Human medical condition
Histology of involved tissue Treatment Chemotherapy (R-CHOP) Medication Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone, etoposide, prednisolone
Epstein–Barr virus positive diffuse large B-cell lymphoma
Epstein–Barr_virus_positive_diffuse_large_B-cell_lymphoma
Type of cancer
treatment will produce a prolonged remission. Other treatments include rituximab infusion or self-injection with Interferon-alpha. In limited cases, the
Leukemia
Human virus that infects RBC precursors
them were HIV positive. This is a large improvement over administering rituximab. [citation needed] The monoclonal antibody against the CD20 protein has
Parvovirus_B19
Medical condition
glucocorticoid usage. Steroid-sparing agents that have been used include rituximab, azathioprine, methotrexate, and cyclophosphamide, although trials are
IgG4-related_disease
American biotechnology corporation
and young adults with cystic fibrosis—recombinant DNAse. 1997: Rituxan (rituximab): Treatment for specific kinds of non-Hodgkin's lymphomas. In 2006, also
Genentech
Medical study concerned with the kidneys
monoclonal antibodies, are also used in these conditions and include rituximab, basiliximab and eculizumab. Blood products including intravenous immunoglobulin
Nephrology
Blistering autoimmune diseases
such as Rituximab, an anti-CD20 antibody, which was found to improve otherwise severe cases of recalcitrant pemphigus vulgaris. Currently rituximab is considered
Pemphigus
Mammalian protein found in humans
autoimmune diseases. The first anti-CD20 mAb approved by FDA in 1997 was Rituximab, defining a new epoch in hematooncology. The advantages of CD20 as a therapeutic
CD20
Autoimmune disease affecting the peripheral nervous system
are non-responsive to the standard treatment. They are responsive to Rituximab instead. Also some cases of combined central and peripheral demyelination
Chronic inflammatory demyelinating polyneuropathy
Chronic_inflammatory_demyelinating_polyneuropathy
Inflammation of the kidneys
in the immune system cells). Voclosporin can also be used to treat LN. Rituximab and obinutuzumab were also tested for treatment of lupus nephritis. After
Lupus_nephritis
British physician, consultant and professor
RITUXILUP trial, which involved a rituximab treatment regimen. The regimen involved sequential intravenous doses of rituximab and methylprednisolone, and was
Liz_Lightstone
Medication
In November 2025, the FDA approved epcoritamab with lenalidomide and rituximab for relapsed or refractory follicular lymphoma. The FDA also granted traditional
Epcoritamab
Medical condition
addition to these chemotherapy regimens of the immunotherapy agents, Rituximab, which acts to kill B-cells, has greatly improved their effectiveness
Intravascular_lymphomas
Medical condition
chemotherapy, and/or combinations of fludarabine, cyclophosphamide, and rituximab (the latter regimen has been associated with a 2.38-fold higher risk of
Richter's_transformation
Chemotherapy combined with immunotherapy
fight cancer. A common chemoimmunotherapy regimen is CHOP combined with rituximab (CHOP-R) for B-cell non-Hodgkin lymphomas. Cancer treatment has progressed
Chemoimmunotherapy
Medical condition
agents or for refractory lung and muscle disease. Cyclophosphamide, rituximab, tacrolimus, mycophenolate mofetil, and azathioprine are often used alongside
Antisynthetase_syndrome
Overview article
where applicable Mitoxantrone and rituximab: Human anti-chimeric antibodies (HACA) appear in patients treated with Rituximab. MTX reduces them. A safety analysis
Multiple sclerosis drug pipeline
Multiple_sclerosis_drug_pipeline
brimonidine Alphagan Open-angle glaucoma or ocular hypertension Allergan rituximab Rituxan Non-Hodgkin's lymphoma and rheumatoid arthritis Genentech ranibizumab
Annual pharmaceutical drug sales
Annual_pharmaceutical_drug_sales
Medical condition
treatment (including rituximab) after simple drainage of the effusion. These cases suggest that, in addition to the presence of rituximab-sensitive CD20-bearing
Primary_effusion_lymphoma
Aspect of healthcare
CoQ10. A potential use for rituximab was identified by two Norwegian doctors who were treating people who had cancer with rituximab; two people also had chronic
Management_of_ME/CFS
Topics referred to by the same term
soft-tissue injuries RICE (chemotherapy), a chemotherapy regimen containing Rituximab, Ifosfamide, Carboplatin and Etoposide Radio Ice Cherenkov Experiment
Rice_(disambiguation)
Medical condition
used in combination with corticosteroids to manage disease symptoms. Rituximab is a monoclonal antibody therapy targeting CD20 that has been used to
Pemphigus_erythematosus
American pharmaceutical company
relapsing-remitting multiple sclerosis". The Pharma Letter. "FDA Approval for Rituximab". National Cancer Institute. Archived from the original on 2015-04-06
Biogen
Group of disorders
either R-CHOP (rituximab, chimeric anti-CD20 monoclonal antibody, cyclophosphamide, doxorubicin, vincristine, and prednisone or R-EPOCH rituximab, etoposide
Epstein–Barr virus–associated lymphoproliferative diseases
Epstein–Barr_virus–associated_lymphoproliferative_diseases
Type of cancer of lymph nodes
drugs (cyclophosphamide, doxorubicin, vincristine, and prednisone) plus rituximab. R-CHP with polatuzumab vedotin, an antibody-drug conjugate, was included
Non-Hodgkin_lymphoma
American physician (born 1949)
therapies for multiple sclerosis (MS). He led a clinical trial investigating rituximab, a monoclonal antibody targeting CD20+ B cells, which demonstrated efficacy
Stephen_L._Hauser
Blood disorder in which cold sensitive antibodies target red blood cells
response to rituximab is seen on average within 1 to 2 months of treatment and the effect of the treatment lasts for about 1 to 2 years. Rituximab may be used
Cold_agglutinin_disease
Autoimmune disease
diseases. One study from 2014 showed some potential of the synthetic drug Rituximab in treating this class of overlap syndromes. Jablonska S.; Blaszczyk M
Scleromyositis
Autoimmune disease of skin and muscle
chloroquine, are used to treat the rashes, as is done for similar conditions. Rituximab is used when people do not respond to other treatments. As of 2016, treatments
Dermatomyositis
Medical condition
dose of glucocorticoids in combination with either cyclophosphamide or Rituximab. In cases of life threatening disease treatment with plasmapheresis can
Microscopic_polyangiitis
Protein(s) forming a major part of an organism's immune system
doi:10.1056/NEJMoa062382. PMID 17287478. Plosker GL, Figgitt DP (2003). "Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic
Antibody
of the anti-CD20 monoclonal antibody rituximab, it is called R-CEPP(B). R-CEPP(B) regimen consists of: Rituximab - a monoclonal antibody that is able
CEPP
Medical condition
treating the underlying cancer, if present Medication Azathioprine, rituximab, lacosamide Prognosis Variable, recovery rates range from seven in eight
Morvan's_syndrome
RITUXIMAB
RITUXIMAB
RITUXIMAB
RITUXIMAB
Girl/Female
Tamil
Generous
Boy/Male
American, British, English
Little Rock
Girl/Female
Italian
Lady. From the respectful title Donna.
Boy/Male
Hindu
Lord Shiva
Boy/Male
Hindu, Indian, Kannada, Tamil, Telugu
Lord Venkateshwara
Boy/Male
Tamil
Giving life, Re animating, Love
Boy/Male
Indian, Punjabi, Sanskrit, Sikh
Knowledge; Intelligent; Understanding
Girl/Female
Hindu
River Yamuna, Surya putri Yamuna
Surname or Lastname
English
English : patronymic from the personal name Clement.
Boy/Male
Arabic, Muslim
Shadow of the Merciful (Allah)
RITUXIMAB
RITUXIMAB
RITUXIMAB
RITUXIMAB
RITUXIMAB